This work is licensed under a Creative Commons Attribution 4.0 International License.
BimEL-V192E
General Information
DCTPep ID DCTPep03045
Peptide Name BimEL-V192E
Sequence PQMVILQLLRFIFRLEWRRH
Sequence Length 20
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Induce apoptosis Bcl-xL/Bac-2 inhibitors BH3 peptides and mimetics
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Bcl-2/Bcl-xL
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep03045
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C125H199N37O25S1
Absent amino acids ACDGKNSTY
Theoretical pI 12.00
Acidic residues 1
Basic residues 5
Polar residues 0
Molecular weight (Average) 2652.25
Molecular weight (Monoisotopic) 2650.52
Common amino acids LR
Net charge 4
Instability index (II) 85.44
Aliphatic index 131.50
Grand average of hydropathicity (GRAVY) 0.085
Half Life
>20 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
? (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 5500
Abs 0.1% (=1 g/l) 2.074
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 30860026
Title Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.